ECARX Holdings, Inc.
NASDAQ:ECXAuto - Parts
-$0.04 today
- Market cap
- $265.48M
- Beta
- 1.00
- P/E (TTM)
- -28.3
- EPS (TTM)
- -$0.04
Volume 1.09M
Average 1.59M
ECX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
ECARX Holdings, Inc.NASDAQ: ECX
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$8.6M, compared with -$18.99M a year earlier. Trailing-twelve-month EBITDA was -$582.19K.
Context
- EBITDA amounted to 3.8% of revenue in FY2025, up 2.2 pp from a year earlier.
- EBITDA grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of -$295.62M (-805.8%) for the fiscal year ending Dec 2026, a slowdown from the +64.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$8.6M-171.7% QoQ
- Last fiscal yearDec 2025
- -$32.64M+64.1% YoY
- LTMMar 2026
- -$582.19K+99.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +54.7% | -1105.0% | -1159.7 pp |
| 1 year | +64.1% | -805.8% | -870.0 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
Mixed currencies · from the income statement
- Latest · FY2025
- (32.64M) USD
- Year-over-year change
- —
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (32.64M) | — |
| FY2024 | 2024-12-31 | (91M) | +20.9% |
| FY2023 | 2023-12-31 | (115M) | +44.0% |
| FY2022 | 2022-12-31 | (205.38M) | -34.5% |
| FY2021 | 2021-12-31 | (152.67M) | — |
EBITDA vs competitors
How ECX compares with its peers on the latest reported figures
- ECX's LTM Mar 2026 EBITDA of -$582.19K is the 7th highest of the 10 companies compared; the peer median is $79.96M.
- Its year-over-year change of +99.4% is the 2nd highest of 10, against a peer median of +10.8%.
- EBITDA amounts to 0.1% of revenue for ECX, versus a peer median of 12.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $528.18M | +98.2% | -14.5% | 8.4% | |
| LTM Mar 2026 | $193.55M | +47.9% | +10.9% | 10.6% | |
| LTM Apr 2026 | $107.75M | -66.4% | -27.1% | 3.7% | |
| LTM Mar 2026 | $93.4M | +544.4% | — | 13.8% | |
| LTM Mar 2026 | $79.96M | +10.8% | +8.1% | 16.3% | |
| LTM Mar 2026 | $70.91M | -82.0% | +77.1% | 2.5% | |
| LTM Mar 2026 | -$582.19K | +99.4% | — | 0.1% | |
| LTM Mar 2026 | -$61.61M | +30.0% | — | 281.1% | |
| LTM Mar 2026 | -$133.33M | +2.4% | — | 635.7% | |
| LTM Apr 2026 | -$184.96M | -56.8% | — | 12.5% | |
| Peer median (excluding ECX) | $79.96M | +10.8% | +8.1% | 12.5% | |
Competitors are the stored peer set for ECX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 · CNY | FY2022 Dec 2022 · CNY | FY2023 Dec 2023 · CNY | FY2024 Dec 2024 · CNY | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Revenue | 2.78B | 3.56B | 4.7B | 5.63B | 847.86M |
| Cost of Revenue | 307.81M | 372.23M | 3.43B | 4.41B | 701.44M |
| Gross Profit | 817.06M | 936.51M | 1.27B | 1.15B | 146.42M |
| Gross Margin | 29.4% | 26.3% | 27.1% | 20.5% | 17.3% |
| Research & Development | 189.76M | 193.18M | 178.36M | 172.56M | 108.73M |
| Selling, General & Admin | 95.37M | 189.9M | 131.4M | 106.46M | 90.2M |
| Operating Expenses | 285.1M | 380.05M | 309.01M | 278.96M | 198.93M |
| Depreciation & Amortization | 10.22M | 16.89M | 17.58M | 26.07M | 19.87M |
| EBITDA | (152.67M) | (205.38M) | (115M) | (91M) | (32.64M) |
| EBITDA Margin | -5.5% | -5.8% | -2.4% | -1.6% | -3.8% |
| Operating Income | (156.91M) | (236M) | (129.47M) | (120.85M) | (52.51M) |
| Operating Margin | -5.6% | -6.6% | -2.8% | -2.1% | -6.2% |
| Interest Income | 13.66M | 13.82M | 30.5M | 22.18M | 3.71M |
| Interest Expense | 131.59M | 44.54M | 79.31M | 133.76M | 23.77M |
| Other Income / Expenses | (26.63M) | 50.14M | (14.3M) | (14.54M) | (15.19M) |
| Income Before Tax | (183.54M) | (1.58B) | (143.77M) | (135.39M) | (67.7M) |
| Pre-Tax Margin | -6.6% | -44.3% | -3.1% | -2.4% | -8.0% |
| Income Tax Expense | 1.08M | 4.21M | (513.92K) | 203.01K | 1.24M |
| Net Income | (184.18M) | (226.71M) | (132.68M) | (127.71M) | (66.04M) |
| Net Margin | -6.6% | -6.4% | -2.8% | -2.3% | -7.8% |
| EPS (Basic) | 1.97 | (8.02) | (2.79) | (2.77) | (0.19) |
| EPS (Diluted) | 1.97 | (8.02) | (2.79) | (2.77) | (0.19) |
| Weighted Avg Shares | 37.5M | 239.3M | 337.41M | 336.64M | 338.66M |
| Weighted Avg Shares (Diluted) | 37.5M | 239.3M | 337.41M | 336.64M | 338.66M |
ECARX Holdings, Inc.
NASDAQ:ECX
Intrinsic Alpha fair value
Locked
Current Price
$0.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.